CRISPR-Cas-based activation of PPARGC1A boosts endogenous mitochondria and enhances cardiac function after myocardial infarction.
基于 CRISPR-Cas 的 PPARGC1A 激活可增强内源性线粒体功能，并在心肌梗死后改善心脏功能。
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2026.02.027
Escobar Mario, Malik Saad A, Srinivasa Mira A, Mendez-Sosa Miguel A, Miller Jessica M, Lydon Samantha L, Luong Sandy N, Mathew Pretty R, Abouleisa Riham R E, Chakravarty Suridh, Pathan Saliha, Mohamed Tamer M A, Ghanta Ravi K, Hilton Isaac B
